Objective.-To determine whether migraineurs may have a systemic deficiency of magnesium. Background.-Magnesium deficiency has been shown to play a potential role in the pathogenesis of migraine, but there are no data on total body magnesium status in migraineurs.
Magnesium (Mg) is an essential intracellular cation and is involved in numerous physiological processes. 1, 2 Based on previous studies showing evidence of Mg reduction in patients with migraine, Mg deficiency may play an important role in migraine biogenesis. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Low levels of Mg induce cerebral arterial vasoconstriction, increase the aggregation of the platelets and thus promote serotonin release, and potentiate the vasoactive action of serotonin. [18] [19] [20] Reduced Mg levels enhance the sensitivity of the N -methyl-Daspartate (NMDA) receptors to glutamate, facilitating the development of cortical spreading depression. [21] [22] [23] The Mg content of the adult human is approximately 24 g (1 mol), and is equally distributed in bone and in soft tissue. 24 Less than 1% of the total body Mg content is present in blood, with approximately 0.3% present in serum. 24 The measurement of serum Mg is widely used to assess total body Mg status, but a normal serum concentration also can occur in the presence of tissue depletion with compensation by the bone Mg pool. 24, 25 Intracellular Mg content (ie, from leukocytes, red blood cells, peripheral lymphocytes, or platelets) has been investigated in the hope that it would serve as a better indicator of Mg status than the serum concentration, but intracellular Mg concentration pools do not seem to correlate with other tissue pools. 3 The free fraction of intracellular Mg recently was reported to be a more sensitive index of Mg deficiency than total serum level. 3 The most accurate methods to assess Mg status are the Mg load test and muscle or bone biopsies. 3, [25] [26] [27] [28] Biopsies obviously are too invasive to serve for routine measurements, but the Mg load test represents an indirect yet reliable method for assessing the total body Mg status. [25] [26] [27] [28] There has been no reported experience with use of this test in patients with migraine.
In the study reported here, we sought to determine the total body Mg status of patients with migraine by administering an oral Mg load and comparing the migraineurs' serum and urinary Mg concentrations with those obtained from healthy subjects.
METHODS
Subjects.-We evaluated 20 patients with migraine (15 women and 5 men; mean age, 37.9 years; age range, 16 to 52 years) and 20 healthy age-matched volunteers (16 women and 4 men; mean age, 39.6 years; age range, 21 to 54 years). The clinical diagnoses of the patients with migraine were based on the headache classification system of the International Headache Society (IHS). 29 Sixteen patients having migraine without aura (IHS 1.1), and 4 patients experiencing migraine with aura (IHS 1.2) were treated. The Mg load test was performed during an attackfree period in all patients. Patients and subjects with a history of Mg supplementation within the year prior to the load test or those with special dietary habits were excluded from the study. To reduce the methodological limitations resulting from differences in body weight, we selected subjects who had a normal body mass index and less than 10% variation in body weight from fellow subjects. Neither the controls nor the patients were taking any medication known to interfere with Mg status. Alcohol intake and heavy physical activity were not allowed during the collection periods.
Magnesium Loading and Sample Collection.-The Mg load test was performed on 2 consecutive days. In order to determine the baseline serum Mg levels and the baseline urinary Mg excretions, 5 mL of blood was obtained from the antecubital vein in Vacutainer (Becton Dickinson, Franklin Lakes, NJ) glass tubes in the morning of the first day, followed by a 24-hour urine collection.
On the second day, three divided 1000-mg doses of Mg lactate were administered orally to each subject, and a 24-hour urine specimen was collected. To determine the postload serum Mg levels, 5 mL of venous blood was drawn at the end of the second day.
Sample Preparation and Measurement.-The venous blood samples were centrifuged at 3000 rpm for 10 minutes to obtain serum specimens. Samples were stored at Ϫ 20 Њ C for less than 1 week before the determination of serum total Mg. Aliquots of urine from each 24-hour collection period were stored at Ϫ 20 Њ C in plastic tubes for less than 1 week before analysis. The concentration of Mg in serum and urine was measured by a Varian SpectrAA-20 atomic absorption spectrophotometer. The concentrations were expressed as mmol/L. The total excretion (mmol/24 hours) was calculated by multiplying the urinary Mg concentration by the volume of daily excreted urine. Since the urinary Mg excretion has a low intraindividual coefficient of variation, the urinary Mg excretions were not calculated with correction for the creatinine excretion. 30 In our laboratory, the reference ranges for Mg concentration are 0.70 to 1.00 mmol/L for serum, and 2.2 to 5.6 mmol/24 hours for urine.
Statistical Analysis.-Statistical analysis was performed using Statistica for Windows version 5.1 statistical package (StatSoft, Inc, Tulsa, Okla). Based on the variables showing Gaussian distributions, a paired t test was used to assess the difference between the baseline and postload serum and urinary Mg data within the groups, and an unpaired Student t test was performed to assess the difference for Mg data between the groups. Pearson correlation was used to assess the correlation between the serum and 24-hour urine Mg concentration values in the preload and postload period within the groups. The statistical significance of the correlations was calculated using an F test, and P Ͻ .05 was considered as significant.
RESULTS
The mean serum and 24-hour urine Mg concentrations obtained before and after Mg loading are listed in the Table. The baseline serum Mg values were within the reference range in both groups, while the baseline Mg values from the 24-hour urine collection were below normal in four migraineurs and in one control subject.
As indicated in the Figure, the baseline serum Mg concentrations and urinary excretions increased in all subjects after Mg loading. Although the serum Mg levels were somewhat lower in the patients with migraine than in the controls before and after Mg administration, this difference was not significant. Preload urinary Mg excretion was lower in the patients with migraine than in the normal subjects, but the difference, too, was not significant ( P ϭ .064). After loading, however, the Mg excretion of the patients with migraine was significantly lower than that of the controls ( P ϭ .0007) ( Figure 1B) .
Within the groups, significant correlations were not found in the comparison of serum Mg concentrations with 24-hour urine excretion values in either the preload or the postload periods.
COMMENTS
Previous ictal and interictal studies of patients with migraine have revealed reduced levels of Mg concentrations in serum, 7, 9, 12, 14, 15 6, 17 In other investigations, a deficiency of Mg has been less evident or altogether lacking. 7, 13, 14, 16, 32, 33 Measurements of intracellular and ionized Mg concentrations are sensitive methods for demonstrating Mg deficiency, but because there is little evidence for dynamic equilibrium among body tissues, these methods give only limited information about total body Mg status. 34 Furthermore, aside from ionized Mg, none of these methods have been validated, with a reference value established. 3 For this reason, we chose the widely accepted Mg loading test in our effort to determine whether systemic Mg deficiency exists in patients with migraine.
The baseline serum and urine Mg concentrations recorded in our migraine and control groups did not differ significantly. These results are consistent with previous reports showing normal total serum Mg levels in patients with migraine in both the ictal and interictal states. 7, 12, 13, 16 The 24-hour urine excretion of Mg may be a better indicator of tissue status than the serum Mg concentration, but urinary Mg excretion is highly variable and so cannot be used reliably to assay a given individual's Mg status. 35 After loading, Mg levels in serum and in excreted urine increased significantly in both of our subject groups, simply demonstrating the absorption and bioavailability of orally administered Mg. Urinary Mg excretion did not correlate with serum Mg concentration indicating that renal excretion values reflect the complex interrelations of the different Mg pools. 35 The postload serum Mg concentrations did not differ between our two groups, but the Mg content in the excreted 24-hour urine was significantly lower in the migraine group than in the control group. In short, our patients with migraine retained more Mg than our control subjects, and such retention is considered to reflect systemic Mg deficiency. 35 There are numerous etiologies for primary and secondary Mg deficiency. Deficiency may be due to reduced dietary intake, smoking, consumption of alcohol, intestinal malabsorption and defective membrane transport, stress, or genetically impaired intracellular regulations. 31, [36] [37] [38] Females have a greater tendency for Mg deficiency than males, presumably due to their hormonal status. 39 The origin of the Mg deficiency which appears to exist in migraine is unclear.
Based on the possible link between Mg deficiency and migraine, Mg administration has been used as both an acute and a prophylactic therapy. Intravenous Mg sulfate may be effective for acute migraine; in the relatively large trial reported, nonresponders exhibited significantly higher baseline total Mg levels than responders. 7 In two double-blind, placebo-controlled studies evaluating oral supplementation for migraine prophylaxis, patients receiving Mg experienced reductions in attack frequency and number of days with headache. 40, 41 In the third trial of Mg prophylaxis, no difference in efficacy was observed between the migraine and placebo groups; poor absorption of the Mg salt selected was blamed for the negative result. 42, 43 In conclusion, the oral Mg load test may represent an effective, noninvasive means for detecting systemic Mg deficiency in patients with migraine. It should be noted that this test requires strict subject cooperation and has not been standardized for routine clinical use. Even so, our data add to the growing amount of literature supporting the role of Mg deficiency in the pathogenesis of migraine.
Baseline and postload magnesium (Mg) concentrations in serum (A) and in 24-hour urine specimens (B) in control subjects and in patients with migraine. The serum and urinary Mg concentrations were significantly higher after loading in both groups. Urinary Mg excretion was significantly less in patients with migraine than in control subjects after the load, while there was no significant difference between the groups in any other comparison.
